BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8858001)

  • 1. Profiles of neuronal thread protein expression in Alzheimer's disease.
    De La Monte SM; Carlson RI; Brown NV; Wands JR
    J Neuropathol Exp Neurol; 1996 Oct; 55(10):1038-50. PubMed ID: 8858001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuritic pathology and dementia in Alzheimer's disease.
    McKee AC; Kosik KS; Kowall NW
    Ann Neurol; 1991 Aug; 30(2):156-65. PubMed ID: 1910274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of neuronal thread protein expression with neuritic sprouting: relevance to Alzheimer's disease.
    de la Monte SM; Xu YY; Wands JR
    J Neurol Sci; 1996 Jun; 138(1-2):26-35. PubMed ID: 8791235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease.
    Dickson TC; King CE; McCormack GH; Vickers JC
    Exp Neurol; 1999 Mar; 156(1):100-10. PubMed ID: 10192781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal thread protein gene modulation with cerebral infarction.
    de la Monte SM; Garner W; Wands JR
    J Cereb Blood Flow Metab; 1997 Jun; 17(6):623-35. PubMed ID: 9236719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal thread protein over-expression in brains with Alzheimer's disease lesions.
    de la Monte SM; Wands JR
    J Neurol Sci; 1992 Dec; 113(2):152-64. PubMed ID: 1487753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease.
    Masliah E; Mallory M; Alford M; Hansen LA; Saitoh T
    Lab Invest; 1993 Nov; 69(5):562-9. PubMed ID: 8246448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
    de la Monte SM; Volicer L; Hauser SL; Wands JR
    Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
    Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
    Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thy-1 in hippocampus: normal anatomy and neuritic growth in Alzheimer's disease.
    Leifer D; Kowall NW
    J Neuropathol Exp Neurol; 1992 Mar; 51(2):133-41. PubMed ID: 1347079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain.
    Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ
    Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AD7C-NTP neuronal thread protein biomarker for detecting Alzheimer's disease.
    de la Monte SM; Wands JR
    Front Biosci; 2002 Apr; 7():d989-96. PubMed ID: 11897561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease.
    Kowall NW; Kosik KS
    Ann Neurol; 1987 Nov; 22(5):639-43. PubMed ID: 3122646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid.
    Monte SM; Ghanbari K; Frey WH; Beheshti I; Averback P; Hauser SL; Ghanbari HA; Wands JR
    J Clin Invest; 1997 Dec; 100(12):3093-104. PubMed ID: 9399956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads.
    Schmidt ML; Lee VM; Trojanowski JQ
    Lab Invest; 1991 Mar; 64(3):352-7. PubMed ID: 1706004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease.
    Thal DR; Härtig W; Schober R
    J Hirnforsch; 1998; 39(2):175-81. PubMed ID: 10022341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.